Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lili Song, Shikai Liu & Sufen Zhao. (2022) Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway. Bioengineered 13:4, pages 11240-11257.
Read now
Read now
Articles from other publishers (3)
Yue Hu, Lin Yang & Yu Lai. (2023) Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms. Biomedicine & Pharmacotherapy 162, pages 114585.
Crossref
Crossref
Md. Ataur Rahman, Kazi Rejvee Ahmed, Farzana Haque, Moon Nyeo Park & Bonglee Kim. (2023) Recent Advances in Cellular Signaling Interplay between Redox Metabolism and Autophagy Modulation in Cancer: An Overview of Molecular Mechanisms and Therapeutic Interventions. Antioxidants 12:2, pages 428.
Crossref
Crossref
Chuanshan Yao & Feng Wang. (2022) Inhibition of hypoxia‐induced HIF‐1α‐mediated autophagy enhances the in vitro antitumor activity of rhein in pancreatic cancer cells. Journal of Applied Toxicology 42:12, pages 1937-1947.
Crossref
Crossref